HbA1c is calculated by measuring the percentage of hemoglobin in your blood that has glucose permanently attached to it. The result reflects your average blood sugar over roughly the past two to three months, though recent weeks count more heavily than older ones. Understanding how this number is produced, both inside your body and inside the lab, helps explain why it’s such a useful marker for blood sugar control and why it sometimes misses the mark.
How Glucose Attaches to Hemoglobin
HbA1c forms through a natural chemical reaction that doesn’t require any enzymes. Glucose floating in your bloodstream bumps into hemoglobin molecules inside red blood cells and sticks to a specific spot: the nitrogen-containing tip of hemoglobin’s beta chain. This first attachment is loose and reversible, forming what chemists call a Schiff base. Over the next several hours, that unstable bond rearranges itself into a much more durable connection called a ketoamine. Once that second step completes, the glucose is locked on for the remaining life of the red blood cell.
The higher your blood sugar, the more often glucose collides with hemoglobin, and the more of these permanent attachments form. A red blood cell lives about 90 to 120 days, so the glycated hemoglobin it carries acts as a running diary of blood sugar exposure during that window.
Why Recent Weeks Matter More
Although HbA1c is often described as a “three-month average,” it isn’t an equal average across that entire period. Your body constantly produces new red blood cells and retires old ones. At any given moment, the youngest cells have had less time to accumulate glucose, while the oldest cells are about to be cleared from circulation. This turnover creates a natural weighting: blood sugar levels from the most recent four weeks contribute the most to your result, while glucose levels from 60 to 120 days earlier account for only about 25% of the final number. So a significant change in your blood sugar over the past month will shift your HbA1c more than you might expect.
How Laboratories Measure It
Labs don’t calculate HbA1c from a formula you plug your blood sugar into. They physically measure how much glycated hemoglobin is present in a blood sample relative to total hemoglobin. Several techniques exist, and the choice of method matters because each has different strengths.
High-performance liquid chromatography (HPLC) separates hemoglobin types by pushing the blood sample through a column packed with material that interacts differently with glycated and non-glycated hemoglobin. The machine measures how much of each type comes through and calculates the percentage. HPLC is widely considered a reference-level method.
Immunoassay uses antibodies designed to recognize the specific site where glucose attaches to hemoglobin. When those antibodies bind, the reaction produces a measurable signal proportional to the amount of HbA1c present. Studies comparing immunoassays to HPLC reference methods have found strong correlations (above 0.97), meaning both approaches typically agree closely.
Boronate affinity chromatography takes a different approach. It uses a chemical that binds to any sugar-attached hemoglobin, not just the specific beta-chain site. This can be an advantage for patients with certain hemoglobin variants, though it also introduces its own potential for interference.
Standardization Across Labs
To make sure an HbA1c of 7% means the same thing regardless of which lab processes your blood, two international standardization systems exist. The NGSP (National Glycohemoglobin Standardization Program) reports results as a percentage, the format most commonly used in the United States. The IFCC (International Federation of Clinical Chemistry) reports results in millimoles per mole (mmol/mol), which is more common in Europe and parts of Asia.
The two scales are linked by a straightforward conversion: NGSP (%) = 0.0915 × IFCC (mmol/mol) + 2.15. So an IFCC result of 53 mmol/mol translates to about 7.0% on the NGSP scale. Labs certified by these programs run regular calibration checks against reference methods to keep results consistent.
Converting HbA1c to Average Blood Sugar
Many lab reports now include an “estimated average glucose” (eAG) alongside your HbA1c percentage. This conversion comes from the A1c-Derived Average Glucose (ADAG) study, which tracked people wearing continuous glucose monitors and compared their average readings to their HbA1c results. The formula that emerged is:
eAG (mg/dL) = 28.7 × HbA1c (%) − 46.7
Using this equation, an HbA1c of 6.0% corresponds to an eAG of about 126 mg/dL, while an HbA1c of 8.0% translates to roughly 183 mg/dL. The conversion is useful because most people monitor their daily blood sugar in mg/dL (or mmol/L), and seeing both numbers side by side makes it easier to connect day-to-day readings with the bigger picture. Keep in mind that eAG is a population-level estimate. Individual variation means your personal average glucose could be somewhat higher or lower than the formula predicts.
When the Calculation Can Be Wrong
HbA1c assumes your red blood cells live a normal 90 to 120 days. Anything that shortens or lengthens that lifespan will skew the result, sometimes significantly.
Shortened Red Blood Cell Lifespan
Conditions that destroy red blood cells faster than normal, such as sickle cell disease, certain anemias, or chronic kidney disease, mean each cell has less time to accumulate glucose. The result: HbA1c reads artificially low. Research on people with type 2 diabetes found that over half (52%) had some degree of underestimation due to shortened red blood cell survival. Patients whose red blood cells lived 66 days or fewer showed particularly large discrepancies between their measured HbA1c and their actual glucose levels. This underestimation can mask poor blood sugar control and delay treatment adjustments.
Hemoglobin Variants
Genetic hemoglobin variants like HbS (sickle cell trait) and HbC trait can interfere with HbA1c assays, though the effect depends on which lab method is used. Some HPLC instruments and point-of-care devices produce inaccurate readings in the presence of these variants, while other methods handle them fine. Elevated fetal hemoglobin (HbF) and chemically modified hemoglobin, such as the carbamylated form seen in kidney failure, can also throw off results. If you carry a known hemoglobin variant, your doctor may choose a lab method specifically validated for that variant or use an alternative marker like fructosamine.
Other Factors
Iron deficiency anemia tends to push HbA1c up because red blood cells live longer when iron is scarce. Recent blood transfusions dilute your own glycated hemoglobin with donor hemoglobin, temporarily lowering the reading. Heavy alcohol use and certain medications can also introduce small distortions. None of these make HbA1c useless, but they’re important context when a result doesn’t seem to match day-to-day glucose readings.
What the Numbers Mean in Practice
For most adults, an HbA1c below 5.7% is considered normal, 5.7% to 6.4% indicates prediabetes, and 6.5% or higher on two separate tests confirms a diabetes diagnosis. For people already managing diabetes, the general target is below 7%, though individual goals vary based on age, other health conditions, and risk of low blood sugar episodes. Each 1-percentage-point drop in HbA1c represents a meaningful reduction in the risk of diabetes-related complications, which is why this single number carries so much clinical weight despite its imperfections.